Focus Graphite Inc., an exploration stage company, acquires, explores, and develops mineral properties in Quebec, Canada. The company explores for graphite, iron, copper, rare-earth elements, and gold deposits. Its principal property is the Lac Knife graphite deposit that consists of 57 claims covering an area of 2,986.31 hectares located in the Côte-Nord region of Québec. The company was formerly known as Focus Metals Inc. and changed its name to Focus Graphite Inc. in May 2012. The company is based in Kingston, Canada. Focus Graphite Inc. is a subsidiary of 360House.com, Inc.
Industry, Sector and Symbol
Industry Specialized Health Services
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone613-241-4040
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/29/2019 (Estimated)
OptionableOptionable
Focus Graphite (CVE:FMS) Frequently Asked Questions
What is Focus Graphite's stock symbol?
Focus Graphite trades on the Canadian Venture Exchange (CVE) under the ticker symbol "FMS."
When is Focus Graphite's next earnings date?
Has Focus Graphite been receiving favorable news coverage?
Headlines about FMS stock have been trending positive on Wednesday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Focus Graphite earned a media sentiment score of 2.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days.
Who are some of Focus Graphite's key competitors?
Some companies that are related to Focus Graphite include TRACON Pharmaceuticals (TCON), Viridium Pacific Group (VIR), Indiva (NDVA), Lexagene (LXG), Avinger (AVGR), Mannatech (MTEX), MGC Pharmaceuticals (MXC), Avacta Group (AVCT), Zelda Therapeutics (ZLD), AIT Therapeutics (AITB), Celsion (CLSN), Helix Biopharma (HBPCF), DiaMedica Therapeutics (DMAC), Obalon Therapeutics (OBLN) and ProPhase Labs (PRPH).
What other stocks do shareholders of Focus Graphite own?
Who are Focus Graphite's key executives?
Focus Graphite's management team includes the folowing people:
- Mr. Gary Economo, Pres, CEO, COO & Director (Age 60)
- Ms. Judith T. Mazvihwa-MacLean CMA, MBA, MSc, BSc, Chief Financial Officer (Age 44)
- Dr. Joseph E. Doninger MSc, BSc, Director of Manufacturing & Technology
- Dr. Gordon Chiu, Chief Scientist & VP
How do I buy shares of Focus Graphite?
Shares of FMS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Focus Graphite's stock price today?
One share of FMS stock can currently be purchased for approximately C$0.04.
How big of a company is Focus Graphite?
Focus Graphite has a market capitalization of C$13.09 million.
What is Focus Graphite's official website?
How can I contact Focus Graphite?
The company can be reached via phone at 613-241-4040.
MarketBeat Community Rating for Focus Graphite (CVE FMS)
MarketBeat's community ratings are surveys of what our community members think about Focus Graphite and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
